• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION AIA-900

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION AIA-900 Back to Search Results
Model Number AIA-900
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/15/2020
Event Type  malfunction  
Manufacturer Narrative
Device evaluation by manufacturer: the aia-900, serial number (b)(4), was installed on (b)(6) 2019.A complaint history review and service history review for similar complaints was performed from installation date (b)(6) 2019 through aware date 16mar2020.There were no other similar complaints identified during the searched period.The st aia-pack fsh analyte application manual states the following: evaluation of results quality control in order to monitor and evaluate the precision of the analytical performance, it is recommended that commercially available control samples be assayed daily.The minimum recommendations for the frequency of running internal control material are: after calibration, two levels of controls are run in order to accept the calibration curve.The two levels of controls are also repeated after calibration when certain service procedures are performed (e.G.Temperature adjustment, sampling mechanism changes, maintenance of the wash probe or detector lamp adjustment or change).After daily maintenance, at least two levels of the control should be run in order to verify the overall performance of the tosoh aia system analyzers.If one or more control sample value(s) is out of the acceptable range, it will be necessary to investigate the validity of the calibration curve before reporting patient results.Standard laboratory procedures should be followed in accordance with the regulatory agency under which the laboratory operates.The most probable cause of the reported event was due to biological contamination.
 
Event Description
The customer reported getting out of range low quality control (qc) results of the follicle stimulating hormone (fsh) on their aia-900 analyzer.Technical support specialist (tss) instructed the customer prepare a new set of controls, decontaminate the substrate line, then rerun the controls.Customer successfully completed the qc run within acceptable range.Customer also decontaminated the substrate line and recalibrated fsh without error.No further action required by tosoh.The aia-900 analyzer is functioning as expected.There was no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIA-900
Type of Device
AIA-900
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA   1058623
Manufacturer Contact
bernadette oconnell
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586-23
JA   1058623
MDR Report Key9930635
MDR Text Key207793681
Report Number8031673-2020-00102
Device Sequence Number1
Product Code KHO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K971103
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAIA-900
Device Catalogue Number022930111
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/16/2020
Initial Date FDA Received04/06/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/01/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-